Agios Pharmaceuticals (AGIO) Capital Leases (2019 - 2022)
Agios Pharmaceuticals (AGIO) posted Capital Leases of $276000.0 for Q1 2022, little changed on a QoQ basis from $276000.0 in Q4 2021, and up 11.29% year-over-year from $248000.0 in Q1 2021.
Agios Pharmaceuticals (AGIO) Capital Leases (2019 - 2022) Analysis & Trends
Agios Pharmaceuticals' Capital Leases history runs 4 years deep, the most recent figure standing at $276000.0 for Q1 2022.
- Quarterly Capital Leases rose 11.29% year-over-year to $276000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $276000.0 (up 11.29% YoY) and the FY2021 annual result came in at $276000.0, down 16.62% from the prior year.
- Capital Leases was $276000.0 for Q1 2022 at Agios Pharmaceuticals, roughly flat from $276000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $673000.0 in Q4 2019 and bottomed at $167000.0 in Q2 2021.
- A 4-year average of $340428.6 and a median of $276000.0 in 2021 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2020 — Capital Leases slumped 50.82% — and 2022, when it grew 11.29%.
- Agios Pharmaceuticals' Capital Leases stood at $673000.0 in 2019, then slumped by 50.82% to $331000.0 in 2020, then retreated by 16.62% to $276000.0 in 2021, then changed by 0.0% to $276000.0 in 2022.
- Business Quant data shows AGIO's Capital Leases at $276000.0 in Q1 2022, $276000.0 in Q4 2021, and $167000.0 in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 276,000.00 |
| Dec 31, 2021 | 276,000.00 |
| Jun 30, 2021 | 167,000.00 |
| Mar 31, 2021 | 248,000.00 |
| Dec 31, 2020 | 331,000.00 |
| Sep 30, 2020 | 412,000.00 |
| Dec 31, 2019 | 673,000.00 |